Davidson Kempner Capital Management LP Catalent, Inc. Transaction History

Davidson Kempner Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $11.7 Million - $13.3 Million	-265,700 Reduced 61.38%	167,155 $7.61 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $7.9 Million - $16.7 Million	247,855 Added 133.98%	432,855 $18.8 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $8.41 Million - $13.7 Million	185,000 New	185,000 $12.2 Million

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.